Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.5K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.5K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

867
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
867
Seizures: Classification01:13

Seizures: Classification

1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum fibroblast growth factor-2 and fibroblast growth factor-9 levels in bipolar disorder: Potential biomarkers for mood episodes.

Psychiatry research·2026
Same author

Serum zonulin, brain-derived neurotrophic factor, and oxidative stress levels in individuals using paper (A4) impregnated with synthetic cannabinoids.

Frontiers in psychiatry·2025
Same author

Chest compression quality and retention of skills in basic life support training given to medical school year 5 students.

Turkish journal of emergency medicine·2025
Same author

Second to fourth digit ratio and cognitive functioning in bipolar disorder.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2025
Same author

Comprehensive evaluation of the educational impact and effectiveness of specialized study modules in cross-sectional anatomy: a study on student engagement and learning outcomes.

BMC medical education·2025
Same author

RE-AIM evaluation of accreditation process in Turkey.

BMC medical education·2024

Related Experiment Video

Updated: Feb 28, 2026

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

3.2K

Epilepsy and stigmatization in Turkey.

Ozge Doganavsargil-Baysal1, Buket Cinemre1, Yesim Senol2

  • 1Akdeniz University Medical School, Department of Psychiatry, Antalya, Turkey.

Epilepsy & Behavior : E&B
|June 18, 2017
PubMed
Summary

Psychopathology significantly predicts perceived stigmatization in epilepsy patients, impacting their quality of life. This highlights the need to address mental health in epilepsy care.

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.6K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.4K

Related Experiment Videos

Last Updated: Feb 28, 2026

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

3.2K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.6K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.4K

Area of Science:

  • Neurology
  • Psychiatry
  • Public Health

Background:

  • Epilepsy is frequently associated with patient stigmatization.
  • Research on epilepsy-related stigma in Turkey is limited.
  • Understanding stigma's impact on quality of life and psychopathology is crucial.

Purpose of the Study:

  • To investigate the relationship between perceived stigmatization and psychopathology in epilepsy patients.
  • To determine the effects of stigmatization on the quality of life in individuals with epilepsy.

Main Methods:

  • Patients completed socio-demographic and epilepsy information forms.
  • Psychiatric diagnoses were assessed using the Structured Clinical Interview for DSM-IV (SCID-I).
  • Participants were evaluated using the Symptom Checklist-90-Revised (SCL-90-R), Epilepsy Stigmatization Scale, and SF-36 for quality of life.

Main Results:

  • Perceived stigmatization was reported by a similar percentage of patients.
  • Patients experiencing stigma had more generalized tonic-clonic seizures, injuries, and missed medication.
  • Stigmatized patients exhibited higher rates of suicide attempts, psychiatric diagnoses, and psychopathology scores.
  • Lower quality of life was observed in physical functioning, general health, vitality, social role, and mental health.

Conclusions:

  • Psychopathology is a more significant predictor of stigmatization than seizure control variables.
  • History of suicide attempts, psychiatric diagnosis, and SCL-90-PST scores predicted stigmatization.
  • Addressing psychopathology is essential for mitigating stigma and improving quality of life in epilepsy.